메뉴 건너뛰기




Volumn 226, Issue 5, 2011, Pages 1334-1339

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CASPASE 3; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; METALLOTHIONEIN II; PROTEIN BCL 2; PROTEINASE ACTIVATED RECEPTOR 4; RALOXIFENE;

EID: 79951803204     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22461     Document Type: Article
Times cited : (38)

References (50)
  • 3
    • 4944246588 scopus 로고    scopus 로고
    • Loss of ERbeta expression as a common step in estrogen-dependent tumor progression
    • Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. 2004. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11: 537-551.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 537-551
    • Bardin, A.1    Boulle, N.2    Lazennec, G.3    Vignon, F.4    Pujol, P.5
  • 4
    • 35648959800 scopus 로고    scopus 로고
    • Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario
    • Carruba G. 2007. Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102: 899-911.
    • (2007) J Cell Biochem , vol.102 , pp. 899-911
    • Carruba, G.1
  • 5
    • 0032973606 scopus 로고    scopus 로고
    • Estrogen receptor-beta: Implications for the prostate gland
    • Chang WY, Prins GS. 1999. Estrogen receptor-beta: Implications for the prostate gland. Prostate 40: 115-124.
    • (1999) Prostate , vol.40 , pp. 115-124
    • Chang, W.Y.1    Prins, G.S.2
  • 7
    • 3042681854 scopus 로고    scopus 로고
    • 17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells
    • Chieffi P, Kisslinger A, Sinisi AA, Abbondanza C, Tramontano D. 2003. 17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. Int J Oncol 23: 797-801.
    • (2003) Int J Oncol , vol.23 , pp. 797-801
    • Chieffi, P.1    Kisslinger, A.2    Sinisi, A.A.3    Abbondanza, C.4    Tramontano, D.5
  • 8
    • 33746623315 scopus 로고    scopus 로고
    • Molecular regulation of androgen action in prostate cancer
    • Dehm SM, Tindall DJ. 2006. Molecular regulation of androgen action in prostate cancer. J Cell Biochem 99: 33-44.
    • (2006) J Cell Biochem , vol.99 , pp. 33-44
    • Dehm, S.M.1    Tindall, D.J.2
  • 9
    • 33751243012 scopus 로고    scopus 로고
    • Selective estrogen receptor modulators (SERMS)
    • Diez-Perez A. 2006. Selective estrogen receptor modulators (SERMS). Arq Bras Endocrinol Metabol 50: 720-734.
    • (2006) Arq Bras Endocrinol Metabol , vol.50 , pp. 720-734
    • Diez-Perez, A.1
  • 10
    • 0033775525 scopus 로고    scopus 로고
    • Molecular mechanisms of selective estrogen receptor modulator (SERM) action
    • Dutertre M, Smith CL. 2000. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 295: 431-437.
    • (2000) J Pharmacol Exp Ther , vol.295 , pp. 431-437
    • Dutertre, M.1    Smith, C.L.2
  • 11
    • 61749095503 scopus 로고    scopus 로고
    • The dual, opposing roles of estrogen in the prostate
    • Ellem SJ, Risbridger GP. 2009. The dual, opposing roles of estrogen in the prostate. Ann NY Acad Sci 1155: 174-186.
    • (2009) Ann NY Acad Sci , vol.1155 , pp. 174-186
    • Ellem, S.J.1    Risbridger, G.P.2
  • 13
    • 29244452627 scopus 로고    scopus 로고
    • Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation
    • Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B, Puca GA. 2006. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 312: 340-349.
    • (2006) Exp Cell Res , vol.312 , pp. 340-349
    • Gazzerro, P.1    Abbondanza, C.2    D'Arcangelo, A.3    Rossi, M.4    Medici, N.5    Moncharmont, B.6    Puca, G.A.7
  • 14
    • 0035816730 scopus 로고    scopus 로고
    • Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists
    • Hamilton JR, Frauman AG, Cocks TM. 2001. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 89: 92-98.
    • (2001) Circ Res , vol.89 , pp. 92-98
    • Hamilton, J.R.1    Frauman, A.G.2    Cocks, T.M.3
  • 15
    • 0035106357 scopus 로고    scopus 로고
    • Regulation of methallothionein HH messenger ribonucleic and measures exogenous estrogen receptor-β activity in SAOS-2 and LNCaPLN3 cells
    • Harris HA, Henderson RA, Bhat RA, Komm BS. 2001. Regulation of methallothionein HH messenger ribonucleic and measures exogenous estrogen receptor-β activity in SAOS-2 and LNCaPLN3 cells. Endocrinology 142: 645-652.
    • (2001) Endocrinology , vol.142 , pp. 645-652
    • Harris, H.A.1    Henderson, R.A.2    Bhat, R.A.3    Komm, B.S.4
  • 16
    • 2342558431 scopus 로고    scopus 로고
    • Androgen receptor in prostate cancer
    • Heinlein CA, Chang C. 2004. Androgen receptor in prostate cancer. Endocr Rev 25: 276-308.
    • (2004) Endocr Rev , vol.25 , pp. 276-308
    • Heinlein, C.A.1    Chang, C.2
  • 17
    • 3843145374 scopus 로고    scopus 로고
    • Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates
    • Ho SM. 2004. Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491-503.
    • (2004) J Cell Biochem , vol.91 , pp. 491-503
    • Ho, S.M.1
  • 21
    • 0037105670 scopus 로고    scopus 로고
    • Raloxifene a mixed estrogen agonist/antagonist, induces apoptosis inandrogen-independent human prostate cancer cell lines
    • Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ. 2002a. Raloxifene a mixed estrogen agonist/antagonist, induces apoptosis inandrogen-independent human prostate cancer cell lines. Cancer Res 62: 5365-5369.
    • (2002) Cancer Res , vol.62 , pp. 5365-5369
    • Kim, I.Y.1    Kim, B.C.2    Seong, D.H.3    Lee, D.K.4    Seo, J.M.5    Hong, Y.J.6    Kim, H.T.7    Morton, R.A.8    Kim, S.J.9
  • 22
    • 0036645127 scopus 로고    scopus 로고
    • Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway
    • Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ. 2002b. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Res 62: 3649-3653.
    • (2002) Cancer Res , vol.62 , pp. 3649-3653
    • Kim, I.Y.1    Seong, D.H.2    Kim, B.C.3    Lee, D.K.4    Remaley, A.T.5    Leach, F.6    Morton, R.A.7    Kim, S.J.8
  • 23
    • 0037031813 scopus 로고    scopus 로고
    • Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells
    • Kim HT, Kim BC, Kim IY, Mamura M, Seong DH, Jang JJ, Kim SJ. 2002c. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem 277: 32510-32515.
    • (2002) J Biol Chem , vol.277 , pp. 32510-32515
    • Kim, H.T.1    Kim, B.C.2    Kim, I.Y.3    Mamura, M.4    Seong, D.H.5    Jang, J.J.6    Kim, S.J.7
  • 25
    • 0035266404 scopus 로고    scopus 로고
    • Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays
    • Latil A, Bièche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. 2001. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 61: 1919-1926.
    • (2001) Cancer Res , vol.61 , pp. 1919-1926
    • Latil, A.1    Bièche, I.2    Vidaud, D.3    Lidereau, R.4    Berthon, P.5    Cussenot, O.6    Vidaud, M.7
  • 26
    • 0034126666 scopus 로고    scopus 로고
    • Expression of estrogen receptor (ER)-α and ER-ß in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation
    • Lau K-M, LaSpina M, Long J, Ho S-M. 2000. Expression of estrogen receptor (ER)-α and ER-ß in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175-3182.
    • (2000) Cancer Res , vol.60 , pp. 3175-3182
    • Lau, K.-M.1    LaSpina, M.2    Long, J.3    Ho, S.-M.4
  • 27
    • 0035408472 scopus 로고    scopus 로고
    • Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma
    • Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. 2001. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159: 79-92.
    • (2001) Am J Pathol , vol.159 , pp. 79-92
    • Leav, I.1    Lau, K.M.2    Adams, J.Y.3    McNeal, J.E.4    Taplin, M.E.5    Wang, J.6    Singh, H.7    Ho, S.M.8
  • 28
    • 57049144758 scopus 로고    scopus 로고
    • Prostate cancer 2008:challenges in diagnosis and management
    • Marberger M. 2009. Prostate cancer 2008:challenges in diagnosis and management. Eur Urol 3: 89-96.
    • (2009) Eur Urol , vol.3 , pp. 89-96
    • Marberger, M.1
  • 30
    • 0033517825 scopus 로고    scopus 로고
    • Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein)
    • Medici N, Abbondanza C, Nigro V, Rossi V, Piluso G, Belsito A, et al. 1999. Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein). Biochem Biophys Res Commun 264: 983-989.
    • (1999) Biochem Biophys Res Commun , vol.264 , pp. 983-989
    • Medici, N.1    Abbondanza, C.2    Nigro, V.3    Rossi, V.4    Piluso, G.5    Belsito, A.6
  • 31
    • 0035884610 scopus 로고    scopus 로고
    • Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP)
    • Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. 2001. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61: 6777-6782.
    • (2001) Cancer Res , vol.61 , pp. 6777-6782
    • Mentor-Marcel, R.1    Lamartiniere, C.A.2    Eltoum, I.E.3    Greenberg, N.M.4    Elgavish, A.5
  • 36
    • 0034999987 scopus 로고    scopus 로고
    • Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues
    • Pasquali D, Rossi V, Esposito D, Abbondanza C, Puca GA, Bellastella A, Sinisi AA. 2001a. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 86: 2051-2055.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 2051-2055
    • Pasquali, D.1    Rossi, V.2    Esposito, D.3    Abbondanza, C.4    Puca, G.A.5    Bellastella, A.6    Sinisi, A.A.7
  • 38
    • 0033621962 scopus 로고    scopus 로고
    • 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
    • Perillo B, Sasso A, Abbondanza C, Palumbo G. 2000. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901.
    • (2000) Mol Cell Biol , vol.20 , pp. 2890-2901
    • Perillo, B.1    Sasso, A.2    Abbondanza, C.3    Palumbo, G.4
  • 40
    • 0344142396 scopus 로고    scopus 로고
    • Emerging roles of caspase-3-3 in apoptosis
    • Porter AG, Jänicke RU. 1999. Emerging roles of caspase-3-3 in apoptosis. Cell Death Differ 6: 99-104.
    • (1999) Cell Death Differ , vol.6 , pp. 99-104
    • Porter, A.G.1    Jänicke, R.U.2
  • 41
    • 0008881181 scopus 로고    scopus 로고
    • Mutually exclusive expression patterns of Bcl-2 and PAR-4 in human prostate tumors consistent with down-regulation of Bcl-2 by PAR-4
    • Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM. 1999. Mutually exclusive expression patterns of Bcl-2 and PAR-4 in human prostate tumors consistent with down-regulation of Bcl-2 by PAR-4. Oncogene 18: 623-631.
    • (1999) Oncogene , vol.18 , pp. 623-631
    • Qiu, G.1    Ahmed, M.2    Sells, S.F.3    Mohiuddin, M.4    Weinstein, M.H.5    Rangnekar, V.M.6
  • 43
    • 33644895429 scopus 로고    scopus 로고
    • Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: Results from preclinical studies and a pilot phase II clinical trial
    • Shazer RL, Jain A, Galkin AV, Cinman N, Nguyen KN, Natale RB, Gross M, Green L, Bender LI, Holden S, Kaplan L, Agus DB. 2006. Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: Results from preclinical studies and a pilot phase II clinical trial. BJU Int 97: 691-697.
    • (2006) BJU Int , vol.97 , pp. 691-697
    • Shazer, R.L.1    Jain, A.2    Galkin, A.V.3    Cinman, N.4    Nguyen, K.N.5    Natale, R.B.6    Gross, M.7    Green, L.8    Bender, L.I.9    Holden, S.10    Kaplan, L.11    Agus, D.B.12
  • 45
    • 34547375041 scopus 로고    scopus 로고
    • Selective estrogen receptor modulators to prevent treatment-related osteoporosis
    • Smith MR. 2005. Selective estrogen receptor modulators to prevent treatment-related osteoporosis. Rev Urol 7: S30-S35.
    • (2005) Rev Urol , vol.7
    • Smith, M.R.1
  • 46
    • 33750688843 scopus 로고    scopus 로고
    • Treatment-related osteoporosis in men with prostate cancer
    • Smith MR. 2006. Treatment-related osteoporosis in men with prostate cancer. Clin Cancer Res 12: 6315s-6319s.
    • (2006) Clin Cancer Res , vol.12
    • Smith, M.R.1
  • 49
    • 22344444907 scopus 로고    scopus 로고
    • Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor
    • Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K. 2005. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor. Carcinogenesis 26: 1109-1116.
    • (2005) Carcinogenesis , vol.26 , pp. 1109-1116
    • Zeng, Y.1    Yokohira, M.2    Saoo, K.3    Takeuchi, H.4    Chen, Y.5    Yamakawa, K.6    Matsuda, Y.7    Kakehi, Y.8    Imaida, K.9
  • 50
    • 58149116505 scopus 로고    scopus 로고
    • Apoptosis and tumor resistance conferred by PAR-4
    • Zhao Y, Rangnekar VM. 2008. Apoptosis and tumor resistance conferred by PAR-4. Cancer Biol Ther 7: 1867-1874.
    • (2008) Cancer Biol Ther , vol.7 , pp. 1867-1874
    • Zhao, Y.1    Rangnekar, V.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.